COST-EFFECTIVENESS OF MONITORING ENDOXIFEN LEVELS IN BREAST CANCER PATIENTS ADJUVANTLY TREATED WITH TAMOXIFEN
Vreman, R.; van Nuland, M.; ten Ham, R.M.; de Vries-Schultink, A.H.; Rosing, H.; Schellens, J.H.; Beijnen, J.H.; Hovels, A.M.
(2018) Value in Health, volume 21, issue S3, pp.
(Article)
Download/Full Text
Embargo until 2050-01-01
Keywords: adjuvant, endogenous compound, endoxifen, estrogen receptor alpha, tamoxifen, adult, breast cancer, cancer adjuvant therapy, cancer patient, cancer recurrence, cancer survival, clinician, conference abstract, controlled study, cost effectiveness analysis, death, diagnostic test accuracy study, disease free survival, drug efficacy, drug monitoring, drug therapy, female, human, human tissue, major clinical study, Netherlands, probability, quality adjusted life year, sensitivity analysis
ISSN: 1098-3015
Publisher: Elsevier Ltd
(Peer reviewed)